PAVmed (PAVM) Other Accumulated Expenses (2016 - 2024)
PAVmed's quarterly Other Accumulated Expenses came in at $652000.0 in Q4 2024, up 183.48% quarter-over-quarter from $230000.0 in Q2 2020.
PAVmed has reported Other Accumulated Expenses for 6 years, with the latest figure at $652000.0 in Q4 2024.
- For the quarter ending Q4 2024, Other Accumulated Expenses changed N/A year-over-year to $652000.0; the trailing twelve-month figure through Dec 2024 stood at $652000.0 (changed N/A YoY), and the FY2024 full-year result was $652000.0, changed N/A from the prior year.
- Other Accumulated Expenses for Q4 2024 stood at $652000.0, up from $230000.0 in the prior quarter.
- The five-year high for Other Accumulated Expenses was $652000.0 in Q4 2024, with the low at $160000.0 in Q1 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | PAVmed | 4.15 Mn | -9.02 Mn | -703,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 652,000.00 |
| Jun 30, 2020 | 230,000.00 |
| Mar 31, 2020 | 160,000.00 |
| Dec 31, 2019 | 88,000.00 |
| Jun 30, 2019 | 191,933.00 |
| Mar 31, 2019 | 41,090.00 |
| Dec 31, 2018 | 49,872.00 |
| Sep 30, 2018 | 55,311.00 |
| Jun 30, 2018 | 94,247.00 |
| Mar 31, 2018 | 3,108.00 |
| Dec 31, 2017 | 11,203.00 |
| Sep 30, 2017 | 51,750.00 |
| Jun 30, 2017 | 69,000.00 |
| Dec 31, 2016 | 28,000.00 |